Walgreens BootsUS9314271084WBAWBA
Financials
Market Cap
$18.13B5Y beta
0.72EPS (TTM)
$0.665Free Float
712.64MP/E ratio (TTM)
31.62Revenue (TTM)
$142.41BEBITDA (TTM)
$4.40BFree Cashflow (TTM)
-$2.19BPricing
Analyst Ratings
The price target is $25.66 and the stock is covered by 18 analysts.
Buy
2
Hold
11
Sell
5
Information
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. Its segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.